This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This initial export to Brazil marks Avicanna ’s first commercial export of psychoactive Cannabis Extracts into the emerging Brazilian medicinal cannabis market and the delivery of the initial purchase order from the previously announced three (3) year master supply agreement.
Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.
Inhalation of cannabis extracts allows for a faster onset and higher bioavailability than tinctures and oils, and now that doctors can monitor a patient’s metered-dosage, more accurate patient data. Kanabo’s medical line aims to enable patients to move away from the harmful habit of smoking medical cannabis flowers.
This initial export to Austria marks Avicanna’s first commercial export of psychoactive THC Cannabis Extracts into the emerging European medicinal cannabis market. Initial shipment of THC extracts into the European Union.
The lack of research is one of the many reasons that cannabis remains federally illegal. But one of the barriers to conducting the necessary research is its federally illegal status. These intertwining factors plaguing cannabis research must be eradicated for the sake of medical cannabis consumers. . Residue Solvents.
The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. The collaboration represents the Company’s first funded study with a research institution in the United States. organization to help advance scientific research into the potential medical benefits of cannabinoids.
The German government is now funding cannabis research on cannabinoid extractions and additives to food. It is easy to categorize this development in the big bucket of the times they are a’changing—and at a rather rapid pace. That is a big story. . However, here is the strange dichotomy at play within the German government.
CSE: MXT) (OTCQB: MXTTF) is known for its award-winning extraction equipment, but recently, the company refocused its efforts on its proprietary health-related databases, machine learning analysis, and plans to engage in B2B licensing and mHealth. Data Bridge Market Research believes that psychedelics will grow at a 13.3%
The new Radicle Science-OBX alliance fills an unmet need for rigorous scientific research in the cannabis industry and sets a new gold standard for CBD and minor cannabinoid product development.
Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).
Desai brings to Ehave the ability to visualize opportunities and execute creative strategic solutions, while developing deep networks and relationships within the industry. Research in the area of mental health has been Dr. Nitin Desai’s passion. Ben Kaplan, CEO of Ehave, Inc. Forward-Looking Statement Disclaimer.
This issue is compounded when veterans do, on rare occasions, ask their doctors about medical marijuana, only to be treated as if they are mentally unstable or receive no specific health information at all,” the researchers found. This directly conflicts with past research claiming marijuana increases PTSD symptom severity.”.
HHC was synthesized in Adams’ laboratory as part of research to understand the active compounds in the cannabis plant. The importance of this finding is that, similar to CBN, HHC may occur naturally as a degradation product in aged cannabis, extracts, and concentrates. Hexahydrocannabinol (HHC). What is hydrogenation?
Researchers Inspected Cannabis Products for Contaminants. Dr. Maxwell’s team also collected data contained in samples sourced from California. There was more inconsistency in cannabis-borne contaminant regulation as compared with other agricultural commodities,” wrote the researchers. for extracts.
MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD.
Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate. D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted.
Based on 2020 data from Health Canada, approximately 37% of Canadian cannabis consumers were users of vape pens, e-cigarettes, and vapourizers 1. With the introduction of “Cannabis 2.0” With the introduction of “Cannabis 2.0” Such an expansion will ultimately bring CLC’s annual cultivation footprint to over 4.35
With over 100 known cannabinoids in cannabis, staying informed about the latest research is crucial for making informed decisions. Understanding how to discern reliable sources, interpret research methodologies, and apply key findings to real-world scenarios can be daunting.
OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.
The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Today (30 May) at 09.30 Effective, most effective in treatment Relieve symptoms.
Johnson’s primary area of research expertise is the psychopharmacology of medications for treating addictions, and he is well known in the field for his discovery that topiramate, a gamma-aminobutyric acid. July 06, 2021 08:30 ET | Source: Ehave. MIAMI, July 06, 2021 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC ” About Ehave, Inc.
(VANCOUVER, BC , July 26, 2021)— Trait Biosciences ( [link] ), a leading cannabinoid biotechnology research organization, announced that it has completed a C$31 million (US$25.46 Our mission is to develop the world’s most comprehensive integrated approach to cannabinoid science, insights, and technology. About Trait Biosciences.
Currently, two provinces – Yunnan and Heilongjiang – have developed regulations for hemp and CBD, and Jilin province could be the third to do so. It offers a full overview of applicable restrictions – both in general and on a provincial level – in all areas including import/export, extracts and finished products.
And while there is essentially no research to say what CBGA does when taken by humans, CBGA has undergone preliminary (preclinical) research for its effects in seizures, inflammation, diabetes, and even COVID infections. He noted, “The data in the study isn’t really ready for translation to the clinic.” Pain and inflammation.
So, we have a smaller operation [in Portugal], but it’s for the production of flower, whereas Colombia’s for the production of extracts right now based on what’s permitted in those two geographies,” Detwiler said. Securities and Exchange Commission (SEC) filings. “So, View original article.
Each of the country’s Ministry of Health approved cannabis farms and production facilities have developed proprietary medical products, contributing to the global ecosystem and offering relief to patients. Pharmocann : Develops and produces medical cannabis, with a focus on research and development of unique, targetted cannabis strains.
August 08, 2022 09:30 ET | Source: Allied Market Research. 08, 2022 (GLOBE NEWSWIRE) — According to the report published by Allied Market Research, the global hemp clothing market generated $2.29 … portland, OR, Aug. billion in 2021, and is projected to reach $23.02 billion by 2031, growing at a CAGR of 27.1%
Industrial hemp is defined as the fibre of the cannabis plant, which is extracted from the stem and is used to produce a variety of industrial and consumer products. 12 Trade Data Analysis (HS Code: 5302). 15 Industry Events and Developments. between 2021 and 2026 to reach a value of USD 14.6 billion by 2026. HempFlax Group B.V.
Researchers are still in the early stages of learning how exactly cannabinoids affect skin health, but some of the results are compelling. The interaction of cannabis with acne has quite limited medical data and there are few conflicting hypotheses. But how does cannabis actually affect the skin?
With regard to adding CBD to food and beverages, FDA maintains that the data currently available raises safety concerns and encourages parties to share relevant information with FDA. FDA is re-opening the docket to obtain information on “full spectrum” and “broad spectrum” hemp extracts, and how they compare to CBD isolate products.
According to a new study published in the Journal of Cannabis Research, adjunctive marijuana use is associated with improvements in pain and other symptoms in patients with refractory fibromyalgia. For the study researcher examined the long-term use of various types of marijuana preparations (e.g., herbal cannabis, oil extracts, etc.)
Decarboxylation of CBCa (cannabichromene carboxylic acid) from CBGa (cannabigerol acid) results in this CBC extract. In this study, researchers examined studied Bulk CBC Isolate and paw edema. The researchers studied adult mice neural stem progenitor cells (NSPCs) outside the body. The cannabinoid reduces edema. Antibacterial.
Economic Growth and Job Creation of the medical marijuana industry The medical cannabis sector serves as a catalyst for economic expansion and workforce development in regions where it’s legalized. Market research helps identify trends and shifts in consumer preferences, allowing businesses to tailor their offerings accordingly.
Michelle Lujan Grisham’s signature this past spring , became effective June 29 and allows adults 21 and older to possess 2 ounces of cannabis flower, 16 grams of cannabis extract and 800 milligrams of edible cannabis. The post Which SKUs Should You Pursue with Solventless Extraction? ” View original article.
Avicanna”), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products. The Branded Products include Avicanna’s proprietary cannabinoid topical formulations developed through years of extensive research by Avicanna’s team of scientists.
He began treating patients with cannabis extracts and wrote of its many clinical applications. The ECS likely developed as an evolutionary advantage to secure vertebrate survival. This isn’t at all specific to humans – data have shown a variety of responses to cannabis across other vertebrates. Bottom line.
to provide naturally derived psilocybin for research and development of therapeutic products. “As the research and drug development work on psilocybin moves forward, HAVN Life continues to position itself as a supply chain leader, able to meet the demand for naturally derived psilocybin,” he adds.
We’re actively working toward developing new genetics to work on efficacy and assist the patients in Israel still operating with our nurse-run clinics in order to better provide the right dosage and strains for the patients who are referred to us by the Ministry of Health,” Stephen Gardner, Tikun Olam’s chief marketing officer, tells Freedom Leaf.
The scientific content requires data stores far larger than news articles and thus we are encouraged by the architecture behind DASH drive. This would make the first Cannabis genome reference that reflects a living plant where a researcher could acquire a cutting or a seed of the plant. DASH has officially Funded the Project!
The Program Specialist 2 (Cannabis) positions will perform applicant and licensee inspection of physical facilities, adherence to program regulations, development of guidance documents and statement of findings and other duties ensuring licensees are complying with public health and safety best practices. Additional Comments.
The Department of Agriculture’s Agriculture Research Service (USDA-ARS) will oversee the development and will co-locate at Cornell AgriTech. The facility currently maintains seeds and performs research and development on crops like grapes, apples, cherries and Brassica. government in the 1980s. Boor, the Ronald P.
The company benefits from a 365-day cultivation window and has developed proprietary hemp strains tailored for the region alongside state-of-the-art processing and extraction facilities. The Agronomic Research and Data Collection research program is designed to optimize quality and yield of hemp grown in the Imperial Valley. .
Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Validcare contracted with 17 CBD companies and acted as the Contract Research Organization, which included gaining feedback from FDA on the protocol, conducting the study and publishing its results.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content